Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,352 | -328,937 | -226,445 | -145,515 | -71,986 |
| Depreciation Amortization | -276 | 1,203 | 1,393 | 619 | -315 |
| Accounts payable and accrued liabilities | 4,240 | -2,509 | 4,016 | 4,612 | 2,141 |
| Other Working Capital | -6,827 | 8,011 | 7,879 | 3,119 | -4,716 |
| Other Operating Activity | 13,332 | 57,788 | 27,818 | 16,112 | 8,365 |
| Operating Cash Flow | $-86,883 | $-264,444 | $-185,339 | $-121,053 | $-66,511 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -449 | -1,554 | -743 | -678 | -547 |
| Purchase Of Investment | -133,839 | -687,171 | -291,949 | -67,883 | N/A |
| Sale Of Investment | 97,831 | 289,199 | 215,935 | 146,850 | 69,926 |
| Investing Cash Flow | $-36,457 | $-399,526 | $-76,757 | $78,289 | $69,379 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 272,391 | 49,291 | 49,291 | N/A |
| Debt Repayment | N/A | -54,635 | N/A | N/A | N/A |
| Common Stock Issued | 52,536 | 711,995 | 242,577 | 24,975 | 24,970 |
| Other Financing Activity | 0 | -51,518 | -2,304 | -2,069 | 0 |
| Financing Cash Flow | $52,536 | $878,233 | $289,564 | $72,197 | $24,970 |
| Beginning Cash Position | 312,428 | 98,165 | 98,165 | 98,165 | 98,165 |
| End Cash Position | 241,624 | 312,428 | 125,633 | 127,598 | 126,003 |
| Net Cash Flow | $-70,804 | $214,263 | $27,468 | $29,433 | $27,838 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,883 | -264,444 | -185,339 | -121,053 | -66,511 |
| Capital Expenditure | -449 | -1,554 | -743 | -678 | -547 |
| Free Cash Flow | -87,332 | -265,998 | -186,082 | -121,731 | -67,058 |